Heraeus Medical to continue its accredited and successful Continuing Education program for orthopedic nurses and surgical techs through 2023-2024

YARDLEY, Pennsylvania, July 12, 2023- Heraeus Medical, a global leader in joint fixation and infection management, today announced that it will continue sponsorship of its popular and accredited onsite continuing education program,  “Why Bone Cement Matters to Your Patient Outcomes" , through 2023-2024.

The Heraeus Medical continuing education program was designed and developed by Pfiedler Education, a division of AORN and one of the leading providers of medical and nursing education. “Why Bone Cement Matters to Your Patient Outcomes” is accredited for 2.0 contact hours by both the National Center for Competency Testing (NCCT), an independent healthcare credentialing organization and the California Board of Registered Nursing.

The no-cost, hour-long education takes place on-site and is intended for registered nurses, surgical technologists, or other healthcare professionals who want to gain knowledge and skills in the different techniques involved in the application of bone cement. Attendees gain a better understanding of cement properties, cementing best practices and resulting changes in patient outcomes. At the conclusion of the program, participants should be able to:

  • Identify the varying viscosities of, and components that make up, bone cement.
  • Discuss various bone cement application techniques within total knee arthroplasty and total hip arthroplasty.
  • Review how antibiotic loaded bone cement can complement the surgeon’s treatment preferences.
  • Describe best practices with use of bone cements and cementing technique to improve patient outcomes.
  • Demonstrate a working knowledge of cements importance to the operative success in total joint arthroplasty.

The first Heraeus Medical-sponsored event took place in June of 2022. All totaled, 30 programs were conducted at hospitals across the United States in the second half of 2022. Nearly 900 orthopedic healthcare professionals attended these events in 2022, including RN’s, surgical techs and OR staff. Heraeus Medical expects to exceed the number of 2022 on-site events and reach over 1,500 RNs and techs in 2023.

According to Scott Druhot, Vice President of Marketing and Education for Heraeus Medical US, the program was conceived to help make it easier for nurses and surgical techs to gain important insights on cementing techniques. He said, “Fulfilling continuing education requirements can be costly and time-consuming for nurses and technicians. By partnering with a trusted provider like Pfiedler Education, this program removes the costs, makes it convenient and gives attendees relevant knowledge that can produce better patient outcomes.”

Hospitals, healthcare facilities and orthopedic practices interested in hosting a continuing education program can contact their local Heraeus Medical representative or by visiting:

About Heraeus

The Heraeus Group is a broadly diversified and globally leading family-owned technology company, headquartered in Hanau, Germany. The company’s roots go back to a family pharmacy started in 1660. Today, Heraeus bundles diverse activities in the Business Platforms Metals and Recycling, Health, Semiconductor and Electronics as well as Industrials. Customers benefit from innovative technologies and solutions based on broad materials expertise and technological leadership. In the 2022 financial year, the FORTUNE Global 500 listed group generated revenues of €29.1 billion (US$30.6 billion*) with approximately 17,200 employees in 40 countries. Heraeus is one of the top 10 family-owned companies in Germany and holds a leading position in its global markets. (*calculated with 2022 average exchange rate, 1€ = 1.0530 US$)

About Heraeus Medical

Heraeus Medical is a leader in the field of bone cements and biomaterials for surgical orthopedics and trauma surgery. In this way, the company makes a decisive contribution to supporting the surgeon and the surgical team to improving the surgical outcome. In the field of biomaterials, Heraeus Medical focuses on products for use in bone and joint surgery. The core product PALACOS® is considered the gold standard among bone cements and has proven itself in clinical use with over 34 million procedures worldwide.